ID   MKNK1_HUMAN             Reviewed;         465 AA.
AC   Q9BUB5; D3DQ20; D3DQ21; O00312; Q5TC06; Q5TC07; Q6V0N6;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   12-OCT-2022, entry version 198.
DE   RecName: Full=MAP kinase-interacting serine/threonine-protein kinase 1;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018};
DE   AltName: Full=MAP kinase signal-integrating kinase 1;
DE            Short=MAPK signal-integrating kinase 1;
DE            Short=Mnk1;
GN   Name=MKNK1; Synonyms=MNK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH02755.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, PHOSPHORYLATION BY MAPK3/ERK1, AND ACTIVITY REGULATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9155018; DOI=10.1093/emboj/16.8.1921;
RA   Fukunaga R., Hunter T.;
RT   "MNK1, a new MAP kinase-activated protein kinase, isolated by a novel
RT   expression screening method for identifying protein kinase substrates.";
RL   EMBO J. 16:1921-1933(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, PHOSPHORYLATION AT THR-250; THR-255 AND THR-385, AND MUTAGENESIS
RP   OF LYS-78; ASP-232; THR-250; THR-255 AND THR-385.
RC   TISSUE=T-cell;
RX   PubMed=11463832; DOI=10.1128/mcb.21.16.5500-5511.2001;
RA   Knauf U., Tschopp C., Gram H.;
RT   "Negative regulation of protein translation by mitogen-activated protein
RT   kinase-interacting kinases 1 and 2.";
RL   Mol. Cell. Biol. 21:5500-5511(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=15350534; DOI=10.1016/j.yexcr.2004.06.006;
RA   O'Loghlen A., Gonzalez V.M., Pineiro D., Perez-Morgado M.I., Salinas M.,
RA   Martin M.E.;
RT   "Identification and molecular characterization of Mnk1b, a splice variant
RT   of human MAP kinase-interacting kinase Mnk1.";
RL   Exp. Cell Res. 299:343-355(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH EIF4G1 AND EIF4G2.
RX   PubMed=9878069; DOI=10.1093/emboj/18.1.270;
RA   Pyronnet S., Imataka H., Gingras A.-C., Fukunaga R., Hunter T.,
RA   Sonenberg N.;
RT   "Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to
RT   phosphorylate eIF4E.";
RL   EMBO J. 18:270-279(1999).
RN   [8]
RP   PHOSPHORYLATION BY PAK2.
RX   PubMed=15234964; DOI=10.1074/jbc.m407337200;
RA   Orton K.C., Ling J., Waskiewicz A.J., Cooper J.A., Merrick W.C.,
RA   Korneeva N.L., Rhoads R.E., Sonenberg N., Traugh J.A.;
RT   "Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits
RT   phosphorylation and interaction of eIF4G with Mnk.";
RL   J. Biol. Chem. 279:38649-38657(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-221; SER-226 AND
RP   THR-385, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-49; VAL-158; ASN-308 AND GLN-446.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in the response to environmental stress and
CC       cytokines. Appears to regulate translation by phosphorylating EIF4E,
CC       thus increasing the affinity of this protein for the 7-methylguanosine-
CC       containing mRNA cap. {ECO:0000269|PubMed:11463832,
CC       ECO:0000269|PubMed:15350534, ECO:0000269|PubMed:9155018,
CC       ECO:0000269|PubMed:9878069}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11463832,
CC         ECO:0000269|PubMed:9155018};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:11463832, ECO:0000269|PubMed:9155018};
CC   -!- ACTIVITY REGULATION: Phosphorylated and activated by the p38 kinases
CC       and kinases in the Erk pathway. {ECO:0000269|PubMed:9155018}.
CC   -!- SUBUNIT: Interacts with the C-terminal regions of EIF4G1 and EIF4G2.
CC       Also binds to dephosphorylated ERK1 and ERK2, and to the p38 kinases.
CC       {ECO:0000269|PubMed:9878069}.
CC   -!- INTERACTION:
CC       Q9BUB5; P54253: ATXN1; NbExp=6; IntAct=EBI-73837, EBI-930964;
CC       Q9BUB5; Q03060-25: CREM; NbExp=3; IntAct=EBI-73837, EBI-12884642;
CC       Q9BUB5; P42858: HTT; NbExp=18; IntAct=EBI-73837, EBI-466029;
CC       Q9BUB5; P28482: MAPK1; NbExp=10; IntAct=EBI-73837, EBI-959949;
CC       Q9BUB5; Q16539: MAPK14; NbExp=5; IntAct=EBI-73837, EBI-73946;
CC       Q9BUB5; Q96CV9: OPTN; NbExp=3; IntAct=EBI-73837, EBI-748974;
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:11463832};
CC         IsoId=Q9BUB5-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9155018}; Synonyms=MNK1a;
CC         IsoId=Q9BUB5-2; Sequence=VSP_007352;
CC       Name=3; Synonyms=MNK1b;
CC         IsoId=Q9BUB5-3; Sequence=VSP_007352, VSP_017515;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15350534}.
CC   -!- PTM: Dual phosphorylation of Thr-250 and Thr-255 activates the kinase.
CC       Phosphorylation of Thr-385 activates the kinase. MAPK3/ERK1 is one of
CC       the kinases which activate MKNK1/MNK1. Phosphorylation by PAK2 leads to
CC       a reduced phosphorylation of EIF4G1. {ECO:0000269|PubMed:11463832,
CC       ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:15350534,
CC       ECO:0000269|PubMed:9155018}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB000409; BAA19885.1; -; mRNA.
DR   EMBL; AY355461; AAQ84219.1; -; mRNA.
DR   EMBL; AL136373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06900.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06902.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06904.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06905.1; -; Genomic_DNA.
DR   EMBL; BC002755; AAH02755.1; -; mRNA.
DR   RefSeq; NP_001129025.1; NM_001135553.2.
DR   RefSeq; NP_003675.2; NM_003684.5.
DR   RefSeq; NP_945324.1; NM_198973.3.
DR   RefSeq; XP_006711063.1; XM_006711000.1.
DR   RefSeq; XP_016858148.1; XM_017002659.1.
DR   PDB; 2HW6; X-ray; 2.50 A; A/B=37-382.
DR   PDB; 2Y9Q; X-ray; 1.55 A; B=434-451.
DR   PDB; 5WVD; X-ray; 3.00 A; A/B=37-382.
DR   PDBsum; 2HW6; -.
DR   PDBsum; 2Y9Q; -.
DR   PDBsum; 5WVD; -.
DR   AlphaFoldDB; Q9BUB5; -.
DR   SMR; Q9BUB5; -.
DR   BioGRID; 114138; 61.
DR   CORUM; Q9BUB5; -.
DR   ELM; Q9BUB5; -.
DR   IntAct; Q9BUB5; 63.
DR   MINT; Q9BUB5; -.
DR   STRING; 9606.ENSP00000361014; -.
DR   BindingDB; Q9BUB5; -.
DR   ChEMBL; CHEMBL4718; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9BUB5; -.
DR   GuidetoPHARMACOLOGY; 2104; -.
DR   iPTMnet; Q9BUB5; -.
DR   MetOSite; Q9BUB5; -.
DR   PhosphoSitePlus; Q9BUB5; -.
DR   BioMuta; MKNK1; -.
DR   DMDM; 30316115; -.
DR   EPD; Q9BUB5; -.
DR   jPOST; Q9BUB5; -.
DR   MassIVE; Q9BUB5; -.
DR   MaxQB; Q9BUB5; -.
DR   PaxDb; Q9BUB5; -.
DR   PeptideAtlas; Q9BUB5; -.
DR   PRIDE; Q9BUB5; -.
DR   ProteomicsDB; 79072; -. [Q9BUB5-1]
DR   ProteomicsDB; 79073; -. [Q9BUB5-2]
DR   ProteomicsDB; 79074; -. [Q9BUB5-3]
DR   Antibodypedia; 32808; 569 antibodies from 32 providers.
DR   DNASU; 8569; -.
DR   Ensembl; ENST00000649800.1; ENSP00000498083.1; ENSG00000079277.22. [Q9BUB5-1]
DR   Ensembl; ENST00000650026.1; ENSP00000497380.1; ENSG00000079277.22. [Q9BUB5-3]
DR   Ensembl; ENST00000650508.1; ENSP00000498143.1; ENSG00000079277.22. [Q9BUB5-2]
DR   GeneID; 8569; -.
DR   KEGG; hsa:8569; -.
DR   UCSC; uc001cqb.5; human. [Q9BUB5-1]
DR   CTD; 8569; -.
DR   DisGeNET; 8569; -.
DR   GeneCards; MKNK1; -.
DR   HGNC; HGNC:7110; MKNK1.
DR   HPA; ENSG00000079277; Tissue enhanced (pancreas).
DR   MIM; 606724; gene.
DR   neXtProt; NX_Q9BUB5; -.
DR   OpenTargets; ENSG00000079277; -.
DR   PharmGKB; PA30829; -.
DR   VEuPathDB; HostDB:ENSG00000079277; -.
DR   eggNOG; KOG0607; Eukaryota.
DR   GeneTree; ENSGT00940000162886; -.
DR   InParanoid; Q9BUB5; -.
DR   OrthoDB; 669799at2759; -.
DR   PhylomeDB; Q9BUB5; -.
DR   TreeFam; TF314050; -.
DR   PathwayCommons; Q9BUB5; -.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   SignaLink; Q9BUB5; -.
DR   SIGNOR; Q9BUB5; -.
DR   BioGRID-ORCS; 8569; 137 hits in 1116 CRISPR screens.
DR   ChiTaRS; MKNK1; human.
DR   EvolutionaryTrace; Q9BUB5; -.
DR   GeneWiki; MKNK1; -.
DR   GenomeRNAi; 8569; -.
DR   Pharos; Q9BUB5; Tchem.
DR   PRO; PR:Q9BUB5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9BUB5; protein.
DR   Bgee; ENSG00000079277; Expressed in body of pancreas and 205 other tissues.
DR   ExpressionAtlas; Q9BUB5; baseline and differential.
DR   Genevisible; Q9BUB5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0009931; F:calcium-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   IDEAL; IID00679; -.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Translation regulation.
FT   CHAIN           1..465
FT                   /note="MAP kinase-interacting serine/threonine-protein
FT                   kinase 1"
FT                   /id="PRO_0000086334"
FT   DOMAIN          49..374
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..40
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          185..204
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          446..465
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        211
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         55..63
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         78
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:11463832"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         250
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MOD_RES         255
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MOD_RES         385
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11463832,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         165..205
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15350534,
FT                   ECO:0000303|PubMed:9155018"
FT                   /id="VSP_007352"
FT   VAR_SEQ         377..465
FT                   /note="QAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALA
FT                   DGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL -> EQQHNGPDALRS (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15350534"
FT                   /id="VSP_017515"
FT   VARIANT         49
FT                   /note="K -> Q (in dbSNP:rs56351860)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040801"
FT   VARIANT         158
FT                   /note="L -> V (in dbSNP:rs56408722)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040802"
FT   VARIANT         308
FT                   /note="D -> N (in dbSNP:rs55791614)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040803"
FT   VARIANT         446
FT                   /note="R -> Q (in dbSNP:rs34881418)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040804"
FT   MUTAGEN         78
FT                   /note="K->M: Loss of kinase activity; when associated with
FT                   D-232."
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MUTAGEN         232
FT                   /note="D->A: Loss of kinase activity; when associated with
FT                   K-78."
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MUTAGEN         250
FT                   /note="T->A: Loss of kinase activity; when associated with
FT                   T-255."
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MUTAGEN         255
FT                   /note="T->A: Loss of kinase activity; when associated with
FT                   T-250."
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   MUTAGEN         385
FT                   /note="T->D: Constitutively active."
FT                   /evidence="ECO:0000269|PubMed:11463832"
FT   HELIX           44..46
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          48..57
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          59..68
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          74..81
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           87..101
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          110..115
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          117..125
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           132..139
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           144..163
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           214..216
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          217..220
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          271..274
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           277..296
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           337..340
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:5WVD"
FT   HELIX           345..354
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   TURN            359..361
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           365..370
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   TURN            372..375
FT                   /evidence="ECO:0007829|PDB:2HW6"
FT   HELIX           439..441
FT                   /evidence="ECO:0007829|PDB:2Y9Q"
FT   HELIX           443..449
FT                   /evidence="ECO:0007829|PDB:2Y9Q"
SQ   SEQUENCE   465 AA;  51342 MW;  CAE225C35DCB2B43 CRC64;
     MVSSQKLEKP IEMGSSEPLP IADGDRRRKK KRRGRATDSL PGKFEDMYKL TSELLGEGAY
     AKVQGAVSLQ NGKEYAVKII EKQAGHSRSR VFREVETLYQ CQGNKNILEL IEFFEDDTRF
     YLVFEKLQGG SILAHIQKQK HFNEREASRV VRDVAAALDF LHTKDKVSLC HLGWSAMAPS
     GLTAAPTSLG SSDPPTSASQ VAGTTGIAHR DLKPENILCE SPEKVSPVKI CDFDLGSGMK
     LNNSCTPITT PELTTPCGSA EYMAPEVVEV FTDQATFYDK RCDLWSLGVV LYIMLSGYPP
     FVGHCGADCG WDRGEVCRVC QNKLFESIQE GKYEFPDKDW AHISSEAKDL ISKLLVRDAK
     QRLSAAQVLQ HPWVQGQAPE KGLPTPQVLQ RNSSTMDLTL FAAEAIALNR QLSQHEENEL
     AEEPEALADG LCSMKLSPPC KSRLARRRAL AQAGRGEDRS PPTAL
//
